Publicacións en colaboración con investigadores/as de Hospital Universitario Araba (18)

2023

  1. Soy protein/β-chitin sponge-like scaffolds laden with human mesenchymal stromal cells from hair follicle or adipose tissue promote diabetic chronic wound healing

    Biomaterials Advances, Vol. 155

2022

  1. Bioactive and degradable hydrogel based on human platelet-rich plasma fibrin matrix combined with oxidized alginate in a diabetic mice wound healing model

    Biomaterials Advances, Vol. 135

2020

  1. Soy protein and chitin sponge-like scaffolds: From natural by-products to cell delivery systems for biomedical applications

    Green Chemistry, Vol. 22, Núm. 11, pp. 3445-3460

2019

  1. Composite nanofibrous membranes of PLGA/Aloe vera containing lipid nanoparticles for wound dressing applications

    International Journal of Pharmaceutics, Vol. 556, pp. 320-329

  2. Safety and effectiveness of sodium colistimethate-loaded nanostructured lipid carriers (SCM-NLC) against P. aeruginosa: in vitro and in vivo studies following pulmonary and intramuscular administration

    Nanomedicine: Nanotechnology, Biology, and Medicine, Vol. 18, pp. 101-111

2017

  1. Novel nanofibrous dressings containing rhEGF and Aloe vera for wound healing applications

    International Journal of Pharmaceutics, Vol. 523, Núm. 2, pp. 556-566

2016

  1. LL37 loaded nanostructured lipid carriers (NLC): A new strategy for the topical treatment of chronic wounds

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 108, pp. 310-316

2014

  1. A novel strategy for the treatment of chronic wounds based on the topical administration of rhEGF-loaded lipid nanoparticles: In vitro bioactivity and in vivo effectiveness in healing-impaired db/db mice

    Journal of Controlled Release, Vol. 185, Núm. 1, pp. 51-61

2013

  1. RhEGF-loaded PLGA-Alginate microspheres enhance the healing of full-thickness excisional wounds in diabetised Wistar rats

    European Journal of Pharmaceutical Sciences, Vol. 50, Núm. 3-4, pp. 243-252

2004

  1. Bioequivalence of two oral ciprofloxacin tablets formulations

    International Journal of Clinical Pharmacology and Therapeutics, Vol. 42, Núm. 6, pp. 336-341

2003

  1. Comparative bioavailability of two immediate-release tablets of lisinopril/hydrochlorothiazide in healthy volunteers

    International Journal of Clinical Pharmacology and Therapeutics, Vol. 41, Núm. 7, pp. 309-315

  2. In vivo pharmacokinetic-pharmacodynamic relationship and in vitro equivalence of two oral furosemide tablet formulations

    Arzneimittel-Forschung/Drug Research, Vol. 53, Núm. 5, pp. 321-329

  3. In vivo pharmacokinetic-pharmacodynamic relationship and in vitro equivalence of two oral furosemide tablet formulations

    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, Vol. 53, Núm. 5, pp. 321-329

  4. Pharmacokinetics and tissue penetration of pefloxacin plus metronidazole after administration as surgical prophylaxis in colorectal surgery

    International Journal of Clinical Pharmacology and Therapeutics, Vol. 41, Núm. 6, pp. 267-274

2002

  1. In vitro and in vivo equivalence of two oral atenolol tablet formulations

    ARZNEIMITTELFORSCHUNG-DRUG RESEARCH, Vol. 52, Núm. 5, pp. 371-378

  2. Pharmacokinetics and tissue distribution of intravenous pefloxacin for antibiotic prophylaxis in biliary surgery

    Biopharmaceutics and Drug Disposition, Vol. 23, Núm. 7, pp. 293-300

2000

  1. Pharmacokinetics of ofloxacin enantiomers after intravenous administration for antibiotic prophylaxis in biliary surgery

    Journal of Clinical Pharmacology, Vol. 40, Núm. 8, pp. 869-874

1998

  1. Pharmacokinetics and tissue distribution of intravenous ofloxacin for antibiotic prophylaxis in biliary surgery

    Clinical Drug Investigation, Vol. 15, Núm. 6, pp. 491-496